CNCE

Concert Pharmaceuticals, Inc.

Delisted

CNCE was delisted on the 3rd of March, 2023.

53 hedge funds and large institutions have $58M invested in Concert Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
7
Reduced
24
Closed
8
Calls
$54K
Puts
$56K
Net Calls
-$2K
Net Calls Change
-$85K
Name Holding Trade Value Shares
Change
Shares
Change %
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$364 -$82.3K -24,426 -100%
IA
52
IndexIQ Advisors
New York
-$267K -84,631 Closed
Marshall Wace
53
Marshall Wace
United Kingdom
-$143K -45,383 Closed
Truist Financial
54
Truist Financial
North Carolina
-$63K -20,000 Closed
AG
55
Algert Global
California
-$61K -19,300 Closed
XT
56
XTX Topco
Cayman Islands
-$45K -14,305 Closed
CSS
57
Cubist Systematic Strategies
Connecticut
-$39K -12,254 Closed
TSS
58
Two Sigma Securities
New York
-$34K -10,921 Closed
DTL
59
Dynamic Technology Lab
Singapore
-$33K -10,536 Closed